Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study

This publication has 30 references indexed in Scilit:

• Single-institution Experience of SBRT for Lung Metastases in Sarcoma Patients
  American Journal of Clinical Oncology, 2017
• Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
  Radiation Oncology, 2014
• Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
  The Lancet Oncology, 2014
• Stereotactic body radiotherapy for oligometastases
  The Lancet Oncology, 2013
• A retrospective study of SBRT of metastases in patients with primary sarcoma
  Medical Oncology, 2012
• Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
  The Lancet, 2012
• Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
  International Journal of Radiation Oncology, Biology, Physics, 2011
• Oligometastases revisited
  Nature Reviews Clinical Oncology, 2011
• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  European Journal of Cancer, 2009
• Sample size tables for exact single‐stage phase II designs
  Statistics in Medicine, 2001